Skip to content
HowShorted

Flexion Therapeutics Inc short interest in 2020

In 2020, Flexion Therapeutics Inc's disclosed short interest ran from 19.78% of shares outstanding on 15 Jan 2020 to 19.31% on 31 Dec 2020, a change of -0.47 percentage points. The year's high was 26.61% on 15 Jul 2020 and its low 18.60% on 31 Mar 2020, averaging 21.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 34.94 days on 30 Oct 2020. Full history: Flexion Therapeutics Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021

Aggregate net short position time series for Flexion Therapeutics Inc in 2020

2020 in figures

Start of year
19.78% (15 Jan 2020)
End of year
19.31% (31 Dec 2020)
Change
-0.47 pp
High
26.61% (15 Jul 2020)
Low
18.60% (31 Mar 2020)
Average
21.50%
Highest days to cover
34.94 (30 Oct 2020)
SEC filings marked
11

Every report in 2020

Flexion Therapeutics Inc short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202019.78%9.12results (8-K)
31 Jan 202020.48%14.12
14 Feb 202020.26%18.95
28 Feb 202021.03%11.77
13 Mar 202019.24%9.9010-K filed, results (8-K)
31 Mar 202018.60%6.61
15 Apr 202021.47%11.27
30 Apr 202022.57%13.55
15 May 202021.75%10.9710-Q filed, results (8-K)
29 May 202021.56%5.11
15 Jun 202022.58%9.67
30 Jun 202026.11%13.63
15 Jul 202026.61%22.37results (8-K)
31 Jul 202026.24%20.53
14 Aug 202020.61%16.5110-Q filed, results (8-K)
31 Aug 202020.59%24.92
15 Sep 202022.01%23.45
30 Sep 202021.10%16.95
15 Oct 202021.40%19.49results (8-K)
30 Oct 202021.61%34.94
13 Nov 202021.11%17.3710-Q filed, results (8-K)
30 Nov 202020.41%26.97
15 Dec 202019.68%24.47
31 Dec 202019.31%19.43

See also: Flexion Therapeutics Inc's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.